Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

Author： de Jong A.   O'Neill T.   Khan A.Y.   Kwappenberg K.M.C.   Chisholm S.E.   Whittle N.R.   Dobson J.A.   Jack L.C.   St Clair Roberts J.   Offringa R.   van der Burg S.H.   Hickling J.K.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.29, 2002-10, pp. : 3456-3464

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity

By Osen W.   Peiler T.   Ohlschlager P.   Caldeira S.   Faath S.   Michel N.   Muller M.   Tommasino M.   Jochmus I.   Gissmann L.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4276-4286

Elsevier

Access to resources Recommend Favorite

Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines

By Chen C.-H.   Wang T.-L.   Hung C.-F.   Pardoll D.M.   Wu T.-C.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 2015-2022

Elsevier

Access to resources Recommend Favorite

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7

By Daemen T.   Riezebos-Brilman A.   Bungener L.   Regts J.   Dontje B.   Wilschut J.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1082-1088

Elsevier

Access to resources Recommend Favorite

Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts

By Thompson H.S.G.   Davies M.L.   Holding F.P.   Fallon R.E.   Mann A.E.   O'Neill T.   St Clair Roberts J.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 40-49

Elsevier

Access to resources Recommend Favorite

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes

By Cassetti M.C.   McElhiney S.P.   Shahabi V.   Pullen J.K.   Le Poole I.C.   Eiben G.L.   Smith L.R.   Kast W.M.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 520-527

Elsevier

Access to resources Recommend Favorite